Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus Free

Abstract

The immune response to a vaccinia virus recombinant expressing the measles virus haemagglutinin (VV-HA) was compared after parenteral or mucosal immunizations in mice. Parenteral immunizations with 10 p.f.u. VV-HA induced HA-specific antibody-producing cells (IgG > IgA) and HA-specific class I-restricted cytotoxic T lymphocytes (CTL) in the spleen. In contrast, intranasal administrations of 10 p.f.u. of VV-HA induced HA-specific spot-forming cells in the spleen (IgG > IgA) and the lungs (IgA > IgG), and HA-specific CTL in the spleen. Co-immunization by the nasal route with VV-HA and cholera toxin enhanced HA-specific immune responses. Oral immunizations with 10 p.f.u. of VV-HA generated low numbers of HA-specific IgA-producing cells in the lamina propria of the gut, and a weak HA-specific CTL activity in the spleen and mesenteric lymph nodes. Oral co-immunization with VV-HA and cholera toxin greatly enhanced the level of HA-specific spot-forming cells in the lamina propria (IgA ≫ IgG). Interestingly, intrajejunal immunizations with 10 p.f.u. VV-HA alone induced high levels of anti-HA IgG-producing cells in the spleen and anti-HA IgA-secreting cells in the lamina propria of the gut. These data show that (i) VV-HA by the nasal route is immunogenic and generates a measles-specific mucosal immune response in the lung, which represents the primary site of replication of measles virus and that (ii) VV-HA can also induce measles-specific immunity in the intestine provided that it is protected from degradation in the gastrointestinal tract, or that cholera toxin is used as an adjuvant.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-10-2471
1996-10-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/10/JV0770102471.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-10-2471&mimeType=html&fmt=ahah

References

  1. Abraham E., Freitas A. A., Coutinho A. A. 1990; Purification and characterisation of intraparenchymal lung lymphocytes. Journal of Immunology 144:2117–2122
    [Google Scholar]
  2. Albrecht P., Ennis F. A., Saltzman E. J., Krugman S. 1977; Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. Journal of Pediatrics 91:715
    [Google Scholar]
  3. Beauverger P., Buckland R., Wild T. F. 1993a; Establishment and characterisation of murine cells constitutively expressing the fusion, nucleoprotein and matrix protein of measles virus. Journal of Virological Methods 44:199–210
    [Google Scholar]
  4. Beauverger P., Buckland R., Wild T. F. 1993b; Measles virus antigens induce both type-specific and canine distemper virus crossreactive cytotoxic T lymphocytes in mice: localization of a common Ld-restricted nucleoprotein epitope. Journal of General Virology 74:2357–2363
    [Google Scholar]
  5. Beauverger P., Buckland R., Wild T. F. 1994; Measles virus hemagglutinin induces an Ld-restricted CD8+ cytotoxic T lymphocyte response to two specific epitopes. Virology 200:281–283
    [Google Scholar]
  6. Bloom B. R. 1989; Vaccines for the third world. Nature 342:115–120
    [Google Scholar]
  7. Bowen J. C., Nair S. K., Reddy R., Rouse B. T. 1994; Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non replicating antigens. Immunology 81:338–342
    [Google Scholar]
  8. Burlington D. B., Clements M. L., Meiklejohn G., Phelan M., Murphy B. R. 1983; Hemagglutinin-specific antibody responses in immunoglobulin G, A and M isotypes as measured by enzyme-linked immunosorbent assay after primary or secondary infection of humans with influenza A virus. Infection and Immunity 41:540–545
    [Google Scholar]
  9. Czerkinsky C., Prince S. J., Michalek S. M., Jackson S., Russell M. W., Moldoveanu Z., McGhee J., Mestecky J. 1987; IgA antibody producing cells after antigen ingestion: evidence for a common mucosal immune system in humans. Proceedings of the National Academy of Sciences, USA 84:2449–2453
    [Google Scholar]
  10. Drillien R., Spehner D., Kirn A., Giraudon P., Buckland R., Wild T. F., Lecocq J. P. 1988; Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein. Proceedings of the National Academy of Sciences, USA 85:1252–1256
    [Google Scholar]
  11. Galama J. M. D., Lucas J., Vos A. 1978; Lymphocyte-mediated cytotoxicity to cells infected with measles virus. I. Use of in vitro infected leucocytes as autologous target cells; absence of virus-specific cytotoxic lymphocytes. Infection and Immunity 6:240–247
    [Google Scholar]
  12. Galletti R., Beauverger P., Wild T. F. 1995; Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia–measles recombinant viruses. Vaccine 13:197–201
    [Google Scholar]
  13. Gallichan W. S., Johnson D. C., Graham F. L., Rosenthal K. L. 1993; Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. Journal of Infectious Diseases 168:622–629
    [Google Scholar]
  14. Garenne M., Leroy O. 1991; Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 338:903–907
    [Google Scholar]
  15. Giraudon P., Wild T. F. 1985; Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology 144:46–58
    [Google Scholar]
  16. Holmgren J., Lycke N., Czerkinsky C. 1993; Cholera toxin and cholera toxin B-subunit as oral-mucosal adjuvant in antigen vector systems. Vaccine 11:1179–1184
    [Google Scholar]
  17. Jirapinyo P., Thakerngpol K., Chaichanwatanakul K. 1990; Cytopathic effects of measles virus on the human intestinal mucosa. Journal of Pediatric Gastroenterology and Nutrition 10:550–554
    [Google Scholar]
  18. Kulkarni A. B., Connors M., Firestone C.-Y., Morse H. C. III, Murphy B. R. 1993; The cytolytic activity of pulmonary CD8+ lymphocytes, induced by infection with a vaccinia virus recombinant expressing the M2 protein of respiratory syncytial virus (RSV), correlates with resistance to RSV infection in mice. Journal of Virology 67:1044–1049
    [Google Scholar]
  19. Lawson C. M., Bennink J. R., Restifo N. P., Yewdell J. W., Murphy B. R. 1994; Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing Influenza A virus nucleoprotein peptide do not protect mice against challenge. Journal of Virology 68:3505–3511
    [Google Scholar]
  20. Liang X. P., Lamm M. E., Nedrud J. G. 1988; Oral administration of cholera toxin-sendai virus conjugate potentiates gut and respiratory immunity against sendai virus. Journal of Immunology 141:1495–1501
    [Google Scholar]
  21. Lycke N. 1986; A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cells. Scandinavian Journal of Immunology 24:393–403
    [Google Scholar]
  22. McDermott M. R., Bienenstock J. 1979; Evidence for a common mucosal immunology system. I. Migration of B immunoblasts into intestinal, respiratory and genital tissues. Journal of Immunology 122:1892–1898
    [Google Scholar]
  23. McFarlin D. E., Bellini W. J., Mingioli E. S., Behar T. N., Trudget A. 1980; Monospecific antibody to the haemagglutinin of measles virus. Journal of General Virology 48:425–429
    [Google Scholar]
  24. Mazanec M. B., Kaetzel C. S., Lamm M. E., Fletcher D., Nedrud J. G. 1992; Intra-cellular neutralization of virus by immunoglobulin A antibodies. Proceedings of the National Academy of Sciences, USA 89:6901–6905
    [Google Scholar]
  25. Meitin C. A., Small P. A. Jr 1993; Scarification with a vaccinia–influenza recombinant does not stimulate IgA unless the animals auto-or cross-inoculate their oropharynxes. Vaccine 11:1360–1361
    [Google Scholar]
  26. Meitin C. A., Bender B. S., Small P. A. Jr 1991; Influenza immunization: intranasal live vaccinia contrasted with parenteral inactivated vaccine. Vaccine 9:751–756
    [Google Scholar]
  27. Meitin C. A., Bender B. S., Small P. A. Jr 1994; Enteric immunization of mice against influenza with recombinant vaccinia. Proceedings of the National Academy of Sciences, USA 91:11187–11191
    [Google Scholar]
  28. Murphy B. R., Collins P. L., Lawrence L., Zubak J., Chanock R. M., Prince G. A. 1989; Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus–RSV recombinants. Journal of General Virology 70:2185–2190
    [Google Scholar]
  29. Naniche D., Varior-Krishnan G., Cervoni F., Wild T. F., Rossi B., Rabourdin-Combe C., Gerlier D. 1993; Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. Journal of Virology 67:6025–6032
    [Google Scholar]
  30. Niewiesk S., Brinckman U., Bankamp B., Sirak S., Liebert U. G., ter Meulen V. 1993; Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes. Journal of Virology 67:75–81
    [Google Scholar]
  31. Offit P. A., Coupar B. E., Svoboda Y. M., Jenkins R. J. 1994; Induction of rotavirus-specific cytotoxic T lymphocyte by vaccinia-virus recombinants expressing individual rotavirus genes. Virology 198:10–18
    [Google Scholar]
  32. Sabin A. B., Aredriga A. F., Fernandez de Castro J., Sever J. L., Madden D. L., Shekarchi I., Albrecht P. 1983; Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. Journal of the American Medical Association 249:2651–2662
    [Google Scholar]
  33. Tamura S., Samegai Y., Kurata H., Nagamine T., Aizawa C., Kurata T. 1988; Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin-B subunit. Vaccine 6:409–413
    [Google Scholar]
  34. Van Binnendijk R. S., Poelen M. C. M., Kuijpers K. C., Osterhaus A. D. M. E., UytdeHaag F. G. C. M. 1990; The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class-I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Journal of Immunology 144:2394–2399
    [Google Scholar]
  35. Wild T. F., Bernard A., Spehner D., Drillien R. 1992; Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. Journal of General Virology 73:359–167
    [Google Scholar]
  36. Wild T. F., Bernard A., Spehner D., Villeval D., Drillien R. 1993; Vaccination of mice against canine distemper virus induced encephalitis with vaccinia recombinants encoding measles or canine distemper virus antigens. Vaccine 11:438–444
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-10-2471
Loading
/content/journal/jgv/10.1099/0022-1317-77-10-2471
Loading

Data & Media loading...

Most cited Most Cited RSS feed